• Home
  • News
  • U.S. squash athlete Olivia Fiechter accepts public warning

U.S. squash athlete Olivia Fiechter accepts public warning

USADA

Press Release

Colorado Springs, Colo. (November 20, 2020)

USADA announced today that Olivia Fiechter, of Philadelphia, Pa., an athlete in the sport of squash, has accepted a public warning for failing to obtain a Therapeutic Use Exemption (TUE) prior to her use of an otherwise prohibited medication. Fiechter’s violation resulted from her use of the prescription medication spironolactone, which she was using under the care of a physician for a diagnosed medical condition. Fiechter, 25, declared the use of the medication on her doping control form and subsequently obtained a TUE through the established process under international rules authorizing future use of this medication in sport.

Because Fiechter’s positive sample from August 22, 2020 was collected out-of-competition, there are no competitive results to disqualify.

In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.

In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.

Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at This email address is being protected from spambots. You need JavaScript enabled to view it., by phone at 1-877-Play Clean (1-877-752-9253) or by mail.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

The original article can be found here.

Leave a comment

Please login to leave a comment.

Courses

Legal Advisors


Copyright © LawInSport Limited 2010 - 2021. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.